Cargando…
Primary Lung Cancer Organoids for Personalized Medicine—Are They Ready for Clinical Use?
SIMPLE SUMMARY: Identification of novel therapeutic strategies for the treatment of non-small cell lung cancer (NSCLC) remains an urgent need in the area of lung cancer research. Traditional in vitro cell culture systems form one of the corner stones of cancer research. However, the growth of cancer...
Autores principales: | Werner, Raphael S., Kirschner, Michaela B., Opitz, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507762/ https://www.ncbi.nlm.nih.gov/pubmed/34638316 http://dx.doi.org/10.3390/cancers13194832 |
Ejemplares similares
-
Lung Cancer Organoids: The Rough Path to Personalized Medicine
por: Rossi, Rachele, et al.
Publicado: (2022) -
Molecular Research in Chronic Thromboembolic Pulmonary Hypertension
por: Opitz, Isabelle, et al.
Publicado: (2019) -
Patient Selection for Local Aggressive Treatment in Oligometastatic Non-Small Cell Lung Cancer
por: Werner, Raphael S., et al.
Publicado: (2021) -
Tumor organoids for cancer research and personalized medicine
por: Yang, Hui, et al.
Publicado: (2022) -
Application of Patient-Derived Cancer Organoids to Personalized Medicine
por: Shiihara, Masahiro, et al.
Publicado: (2022)